Records 1 - 30 (of 574 Records) |
Query Trace: Variants[original query] |
---|
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) China, 2020
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team et al. China CDC Weekly 2020 10.46234/ccdcw2020.032
Summary:
Not in Science Update
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To Kelvin Kai-Wang, et al. The Lancet. Infectious diseases 2020 0 0. (5) 565-574
Key findings:
|
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2
Shi, Jianzhong et al.bioRxiv 10.1101/2020.03.30.015347
Key findings:
|
A territory-wide study of early COVID-19 outbreak in Hong Kong community: A clinical, epidemiological and phylogenomic investigation
Leung, Kenneth Siu-Sing et al.medRxiv 10.1101/2020.03.30.20045740
Key findings:
|
ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy
Asselta, Rosanna et al.medRxiv 10.1101/2020.03.30.20047878
Key findings:
|
Spread of SARS-CoV-2 in the Icelandic Population.
Gudbjartsson Daniel F, et al. The New England journal of medicine 2020 0 0. (24) 2302-2315
Key findings:
|
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
Williamson Brandi N, et al. bioRxiv : the preprint server for biology 2020 0 0.
Key findings:
|
Guillain-Barré Syndrome Associated with SARS-CoV-2.
Toscano Gianpaolo, et al. The New England journal of medicine 2020 0 0. (26) 2574-2576
Summary:
Case series describing the development of GuillainBarr syndrome 5-10 days after onset of COVID-19 symptoms in 5 Italian patients from 3 hospitals in northern Italy.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.
Eis-Hübinger Anna M, et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2020 0 0. 104381
Key findings:
|
Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Diaz-Guimaraens Borja, et al. JAMA dermatology 2020 0 0. (7) 820-822
Key findings:
|
The race for coronavirus vaccines: a graphical guide.
Callaway Ewen, et al. Nature 2020 0 0. (7805) 576-577
Summary:
Provides a graphical guide on 8 types of SARS-CoV-2 vaccines.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao Bin, et al. The New England journal of medicine 2020 0 0. (19) 1787-1799
Summary:
In an intent-to-treat analysis of patients with severe illness who initiated treatment a median of 13 days after illness onset, those who received lopinavir-ritonavir (vs standard of care alone) experienced no significant differences in clinical improvement (Figure 1) or reductions in viral load over time (Figure 2).
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Hung Ivan Fan-Ngai, et al. Lancet (London, England) 2020 0 0. (10238) 1695-1704
Key findings:
|
COVID-19 in Children With Cancer in New York City.
Boulad Farid, et al. JAMA oncology 2020 0 0. (9) 1459-1460
Key findings:
|
Infection of dogs with SARS-CoV-2.
Sit Thomas H C, et al. Nature 2020 0 0. (7831) 776-778
Key findings:
|
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Grifoni Alba, et al. Cell 2020 0 0. (7) 1489-1501.e15
Key findings:
|
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.
Robbiani Davide F, et al. bioRxiv : the preprint server for biology 2020 0 0.
Key findings:
|
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu Jingyou, et al. Science (New York, N.Y.) 2020 0 0. (6505) 806-811
Key findings:
|
Precision Physical Distancing for COVID-19: An Important Tool in Unlocking the Lockdown.
Bausch Daniel G, et al. The American journal of tropical medicine and hygiene 2020 0 0. (1) 22-24
Summary:
Precision physical distancing may provide a sustainable long-term solution to resuming normal activities.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.
Frieden Thomas R, et al. Emerging infectious diseases 2020 0 0. (6) 1059-1066
Summary:
Discussion of the drivers and prevention of superspreading events of SARS-CoV-2 transmission.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.
Osório Nuno Sampaio, et al. The Lancet. Infectious diseases 2020 0 0. (2) 166-167
Key findings:
|
Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection.
Nardell Edward A, et al. JAMA 2020 0 0. (2) 141-142
Summary:
Air disinfection in hospitals may be used to reduce potential airborne transmission of SARS-CoV-2.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
COVID-19 vaccines start moving into advanced trials.
Mullard Asher, et al. Nature reviews. Drug discovery 2020 0 0. (7) 435
Summary:
Current landscape of leading COVID-19 vaccine candidates.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
Martínez-Perez Oscar, et al. JAMA 2020 0 0. (3) 296-299
Key findings:
|
New-Onset Diabetes in Covid-19.
Rubino Francesco, et al. The New England journal of medicine 2020 0 0. (8) 789-790
Summary:
Explores the interactions of COVID-19 and diabetes mellitus and describes a global registry to track epidemiologic features and pathogenesis of new-onset diabetes with COVID-19.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Considering how biological sex impacts immune responses and COVID-19 outcomes.
Scully Eileen P, et al. Nature reviews. Immunology 2020 0 0. (7) 442-447
Summary:
Thorough review of biological sex, immune responses, and differential COVID-19 outcomes by biological sex.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Interregional SARS-CoV-2 spread from a single introduction outbreak in a meat-packing plant in northeast Iowa
Richmond, Craig S. et al.medRxiv 10.1101/2020.06.08.20125534
Key findings:
|
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
Lu, Jing et al.medRxiv 10.1101/2020.06.15.20131748
Key findings:
|
Monoclonal Antibodies for Prevention and Treatment of COVID-19.
Marovich Mary, et al. JAMA 2020 0 0. (2) 131-132
Summary:
Succinct overview of monoclonal antibodies for prevention and treatment of COVID-19.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City
Stadlbauer, Daniel et al.medRxiv 10.1101/2020.06.28.20142190
Key findings:
|
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure